SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about newspaper clippings

13 Jul 2023 Evaluate

Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emmessar Biotech & Nutrition has informed that it enclosed the newspaper clippings regarding the intimation of Board Meeting, to be held on Thursday, August 10, 2023 at 12:00 Noon, published in The Free Press Journal in English and Navshakti in Marathi, dated July 13, 2023.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

27.49 0.50 (1.85%)
17-Apr-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.10
Dr. Reddys Lab 1221.40
Cipla 1239.90
Zydus Lifesciences 946.80
Lupin 2333.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×